Glioblastoma is a malignant neoplasm that arises from glial cells of the brain. The tumor is heterogeneous and requires a differentiated therapeutic approach.
Details →
Colorectal cancer, encompassing malignancies of the colon and rectum, stands as the third most prevalent cancer globally and ranks second in cancer-related mortality.
Details →
Lung cancer, a leading cause of cancer-related mortality, requires comprehensive treatment strategies to improve outcomes and patient well-being.
Details →
Immunotherapy treats breast cancer by boosting your immune system so it can do more to kill cancerous cells.
Details →
NSCLC accounts for 80-85% of lung cancer cases, with approximately 40,000 annual diagnoses in Germany.
Details →
Colorectal cancer develops in the colon or rectum when abnormal cells grow uncontrollably, often starting as benign polyps that turn malignant.
Details →
Over 400,000 new cases of bladder cancer are diagnosed in the world annually. In 75% of patients, the tumor is detected at an early localized stage.
Details →
While traditional approaches like radiation therapy and chemotherapy show limited effectiveness, modern immunotherapy has revolutionized treatment outcomes at all stages.
Details →
The quality ofhealthcare in some countries is not able to always satisfy the needs of its citizens. People cannot receive adequate care in severe cases or when suffering from a rare disease.
Details →
Lung cancer, one of the leading causes of cancer-related deaths globally, demands innovative approaches to improve survival rates and quality of life.
Details →
A Klatskin tumor, also known as perihilar cancer, is a type of extrahepatic cholangiocarcinoma, which starts in the area where the right and left bile ducts converge to form the common bile duct.
Details →
Pancreatic cancer is an aggressive tumor of the digestive system. One of the reasons for the low effectiveness of treatment for pancreatic tumors is the weak anti-tumor immune response.
Details →
Colon cancer (ICD C18) is one of the five most common malignant tumors in the world, ranking third overall. While the average age of most patients is 60-75 years, the disease can also develop in individuals between 35-50 years old.
Details →
Cancer cells may break away from a tumor in the colon or rectum and spread to other parts of the body through the bloodstream or lymphatic system. These cells may settle and form new tumors on a different organ
Details →
Duodenal cancer is a rare but serious malignancy that develops in the first portion of your small intestine (duodenum), accounting for less than 1% of all gastrointestinal cancers [3].
Details →
Pancreatic cancer (ICD C25) is one of the most common gastrointestinal cancers. More than 300,000 new cases are diagnosed in the world every year.
Details →
Breakthrough interventional radiology cancer treatment is transforming lives with remarkable patient outcomes and minimal recovery time.
Details →
Lutetium Lu-177 PSMA therapy, a cutting-edge targeted radioligand therapy, is transforming the landscape of advanced prostate cancer treatment by delivering precise radiation to cancer cells
Details →
Germany, a global hub for advanced liver cancer care, is reshaping treatment outcomes with innovative therapeutic breakthroughs, attracting liver cancer worldwide.
Details →
